Tag Archives: U.S.

Harvard specialist focuses on opioid crisis as U.S. life expectancy drops

GAZETTE: Do you see the overdose epidemic continuing? McHUGH: It’s hard to say. Unfortunately, last year’s increase of 9.6 percent suggests that the efforts that are now ongoing — and there’s quite a bit of attention on this — are not sufficient. A big part is access to fentanyl and fentanyl analogs, which are extremely potent opioids.… Read More »

Exclusive: Dutch hospitals to drop U.S. body brokers, cite ethical concerns

AMSTERDAM – Two major Dutch hospitals say they will stop importing human body parts from American firms, which they have been doing without any regulation for a decade. Outside view of Erasmus MC Medical Center in Rotterdam, Netherlands December 8, 2018. REUTERS/Eva Plevier The hospitals told Reuters in recent weeks they made their decisions on ethical grounds.… Read More »

American Medical Association report shows competition shrinking in many U.S. health insurance markets

Competition in commercial health insurance markets is shrinking for half the country. That’s the word from the American Medical Association‘s “Competition in Health Insurance: A Comprehensive Study of U.S. Markets” report. The findings showed half of all states had commercial health insurance markets that were less competitive in 2017 than in 2016. The report offers… Read More »

U.S. regulators snip red tape for medical devices to curb opioid crisis

(Reuters) – Laura Perryman expected her medical company, Stimwave Technologies Inc, would have to wait several years for its painkilling device to win U.S. approval as a treatment for chronic migraines. FILE PHOTO: A sign reads “Drug testing in session,” on the bathroom door of an outpatient treatment center in Indiana, Pennsylvania, U.S. on August… Read More »